Xolair (omalizumab) - Roche, Novartis
Nucala (mepolizumab) - GSK
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42731580
 
Adam S DeConde; Bita Naimi; Carol H Yan; Omer Baker; Soraya Mehdipour
 
Sep 13, 2026
 
Prev Next